← back

The whale feed

Who just crossed 5%?

When anyone — family offices, activist funds, sovereign wealth, famous CEOs buying into other companies — crosses a 3–5% voting- rights threshold in an EU or UK listed company, they must disclose it within 2–4 trading days. A different signal from Article 19 PDMR filings — conviction across the table, not inside one.

Filtered bySanthera Pharmaceuticals Holding AG×Clear all
Buy Santhera Pharmaceuticals Holding AG
Pick a broker. We handle the signal, they handle execution.

Affiliate links — we may earn a referral fee if you sign up.

Matching filings

Showing 22 most recent
FiledFilerCompanyMoveNew %Source
2026-05-15
6d ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above0.13%regulator →
2026-05-14
1w ago
🇨🇭Nxera Pharma Co., Ltd.Santhera Pharmaceuticals Holding AG↓ crossed below3.00%regulator →
2026-04-29
3w ago
🇨🇭Catalyst Pharmaceuticals, Inc.Santhera Pharmaceuticals Holding AG↑ crossed above9.39%regulator →
2026-04-28
3w ago
🇨🇭UBS Fund Management (Switzerland) AGSanthera Pharmaceuticals Holding AG↓ crossed below3.00%regulator →
2026-03-29
1mo ago
🇨🇭UBS Fund Management (Switzerland) AGSanthera Pharmaceuticals Holding AG↑ crossed above3.00%regulator →
2026-03-28
1mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above0.55%regulator →
2026-03-19
2mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above0.29%regulator →
2026-03-18
2mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above0.42%regulator →
2026-01-17
4mo ago
🇨🇭Nxera Pharma Co., Ltd.Santhera Pharmaceuticals Holding AG↑ crossed above3.95%regulator →
2026-01-15
4mo ago
🇨🇭Santhera Pharmaceuticals Holding AGSanthera Pharmaceuticals Holding AG↑ crossed above4.72%regulator →
2026-01-14
4mo ago
🇨🇭Santhera Pharmaceuticals Holding AGSanthera Pharmaceuticals Holding AG↑ crossed above8.67%regulator →
2025-10-31
6mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above1.75%regulator →
2025-10-25
6mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above1.75%regulator →
2025-10-21
7mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above1.75%regulator →
2025-10-16
7mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above1.75%regulator →
2025-10-10
7mo ago
🇨🇭Idorsia Pharmaceuticals LtdSanthera Pharmaceuticals Holding AG↓ crossed below3.00%regulator →
2025-10-05
7mo ago
🇨🇭Idorsia Pharmaceuticals LtdSanthera Pharmaceuticals Holding AG↑ crossed above2.85%regulator →
2025-10-04
7mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above0.23%regulator →
2025-09-30
7mo ago
🇨🇭Santhera Pharmaceuticals Holding AGSanthera Pharmaceuticals Holding AG↑ crossed above4.60%regulator →
2025-09-28
7mo ago
🇨🇭JPMorgan Chase & Co.Santhera Pharmaceuticals Holding AG↑ crossed above1.61%regulator →
2025-09-28
7mo ago
🇨🇭Bank of America CorporationSanthera Pharmaceuticals Holding AG↓ crossed below3.00%regulator →
2025-09-27
7mo ago
🇨🇭Bank of America CorporationSanthera Pharmaceuticals Holding AG↑ crossed above0.08%regulator →

Why this signal matters

A CEO buying €1m of their own stock is confidence. A family office quietly accumulating 5% of a small listed industrial is conviction across the table — and often a leading indicator of an activist campaign, a take-private bid, a sovereign wealth allocation, or a cornerstone investment. Academic literature (Brav, Jiang, Kim 2010 on activism; Bebchuk et al 2013) consistently finds substantial outperformance in the months following 13D / equivalent filings in the US. Europe's Transparency Directive is the European equivalent.